SOX2 control activation of dormant prostate cancer cells in bone metastases by promoting CCNE2 gene expression
American Journal of Clinical and Experimental Urology · 2024
DOI: 10.62347/ascy2532 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Urology, 2024. Verfasst von Min Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital, Army Military Medical University Chongqing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital, Army Military Medical University Chongqing, China.
- School of Medicine, Chongqing University Chongqing, China.
- State Key Laboratory of Trauma and Chemical Poisoning, Daping Hospital, Third Military Medical University Chongqing, China.
Zitieren
APA
Deng, M., Huang, P. Z., Huang, Z. Y., Chen, T. T., Luo, X., Liao, C. Y., Xu, W. H., Zhao, J., Wu, Q. J., & Zheng, J. (2024). SOX2 control activation of dormant prostate cancer cells in bone metastases by promoting CCNE2 gene expression. American Journal of Clinical and Experimental Urology. https://doi.org/10.62347/ascy2532
Vancouver
Deng M, Huang PZ, Huang ZY, Chen TT, Luo X, Liao CY, et al. SOX2 control activation of dormant prostate cancer cells in bone metastases by promoting CCNE2 gene expression. American Journal of Clinical and Experimental Urology. 2024. doi:10.62347/ascy2532
BibTeX
@article{Deng2024,
author = {Deng, Min and Huang, Pei-Zheng and Huang, Ze-Yu and Chen, Ting-Ting and Luo, Xing and Liao, Chao-Yu and Xu, Wen-Hao and Zhao, Jiang and Wu, Qing-Jian and Zheng, Ji},
title = {SOX2 control activation of dormant prostate cancer cells in bone metastases by promoting CCNE2 gene expression},
journal = {American Journal of Clinical and Experimental Urology},
year = {2024},
doi = {10.62347/ascy2532}
}
EUVIMED